Thursday, July 7, 2022
TherapeuticsMD (NASDAQ: TXMD) Enters into Agreement to be Acquired by EW Healthcare Partners for $10.00 Per Share
TherapeuticsMD, Inc. (NASDAQ: TXMD) is engaged within the research, development and commercialization of healthcare products for women. Shares of the...
Read more
Apyx Medical (NASDAQ: APYX) Granted FDA 510(k) Clearance to use Renuvion Cosmetic Tech in Dermal Resurfacing Procedures
Apyx Medical Corporation (NASDAQ: APYX) is engaged as a medical device and supplies company, which operates two key innovative products...
Read more
GeoVax Labs (NASDAQ: GOVX) Granted Chinese Patent for Cancer Vaccine
GeoVax Labs, Inc. (NASDAQ: GOVX) is engaged as a biotechnology company, which is focused on the research and development of...
Read more
Catalyst Biosciences (NASDAQ: CBIO) Skyrockets 234% After Selling Assets to Vertex Pharmaceuticals (NASDAQ: VRTX) for $60 Million
Catalyst Biosciences, Inc. is engaged as a biopharmaceutical company, which is focused on the research and development of protease therapeutics...
Read more
Entasis Therapeutics (NASDAQ: ETTX) to be Acquired by Innoviva (NASDAQ: INVA) for $113 Million
Entasis Therapeutics Holdings, Inc. (NASDAQ: ETTX) is engaged as a late-stage clinical biopharmaceutical company, which is focused on the research,...
Read more
Biohaven Pharmaceuticals (NYSE: BHVN) Agrees to be Acquired by Pfizer (NYSE: PFE) for $11.6 Billion
Biohaven Pharmaceuticals (NYSE: BHVN) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development and commercialization...
Read more
Evoke Pharma (NASDAQ: EVOK) Receives FDA Grant of New Drug Product Exclusivity for GIMOTI
Evoke Pharma, Inc. (NASDAQ: EVOK) is engaged as a specialty pharmaceutical company, which is focused on the research and development...
Read more
This Best-in-Class Small-Cap Medical Device Stock Could Continue its Strong Financial Performance Even as Global Economy Stalls
Health care and the various sub-sectors that make up the space continue to be among the highest growth areas of...
Read more
AlloVir (NASDAQ: ALVR) Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Posoleucel, Treatment of Life-Threatening Infections in Allogeneic Hematopoietic Cell Transplant Patients
AlloVir, Inc. (NASDAQ: ALVR) is a late-stage clinical cell therapy company, which is focused on the research, development and commercialization...
Read more
Checkmate Pharmaceuticals (NASDAQ: CMPI) Skyrockets 333% After Agreement to be Acquired by Regeneron (NASDAQ: REGN) for $250 Million
Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) is engaged as a clinical-stage biotechnology company, which is focused on leveraging its proprietary technology...
Read more
